Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.

about

Effect of Pioglitazone in Combination with Moderate Dose Statin on Atherosclerotic Inflammation: Randomized Controlled Clinical Trial Using Serial FDG-PET/CT.

P2860

Q55519195-0AB701C1-42A2-417F-AC48-520833BE8623

P2860

Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.

Item

http://www.wikidata.org/entity/Q41190859

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Combining Potent Statin Therap ...... ile Minimizing Adverse Events.

@en

type

Item

label

Combining Potent Statin Therap ...... ile Minimizing Adverse Events.

@en

prefLabel

Combining Potent Statin Therap ...... ile Minimizing Adverse Events.

@en

P1476

Combining Potent Statin Therap ...... ile Minimizing Adverse Events.

@en

P2093

Ichiro Sakuma

http://www.w3.org/2001/XMLSchema#string

Kazunori Shimada

http://www.w3.org/2001/XMLSchema#string

Kwang Kon Koh

http://www.w3.org/2001/XMLSchema#string

Michael J Quon

http://www.w3.org/2001/XMLSchema#string

Toshio Hayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Hypertriglyceridemia and Cardiovascular Diseases: Revisited

Statins and renin-angiotensin system inhibitor combination treatment to prevent cardiovascular disease

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.

Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.

Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients

Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients.

P304

432-439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4070/KCJ.2016.0406

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28765731

http://www.w3.org/2001/XMLSchema#string

P921

statin therapy

P932

5537141

http://www.w3.org/2001/XMLSchema#string

Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.

about

P2860

P2860

Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932